A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
VALIDATION OF COMPASS FOR PRE-TREATMENT PATIENT-SPECIFIC QUALITY ASSURANCE
2022
Zenodo
Aim: Purpose of study is to validate COMPASS 3D patient specific quality-assurance software with Monaco treatment planning system (TPS) for routine quality assurance. Materials & methods: Purpose is to test the MLC modelling in COMPASS software, using Elekta Express QA package contains eight QA fields as follows (i) 10x10 (ii) 20x20 (iii) 3ABUT (iv) DMLC1 (v) HIMRT (vi) HDMLC(vii) 7SegA (viii) Four L were measured with COMPASS and compared with Monaco TPS. For clinical validation of COMPASS,
doi:10.5281/zenodo.6580175
fatcat:zpxytq42lvgnpmne6drxn5odtq